source
- Lilly showcases Jaypirca combination data in CLL at EHA26, debuting results from Ajax acquisitionEli Lilly highlighted new blood‑cancer data at the European Hematology Association meeting in Stockholm. The company presented early clinical results for its Jaypirca therapy combined with the stan…
- Medicaid fraud crackdown threatens home care for disabled, risking loss of essential servicesStates are adopting a Medicaid fraud enforcement strategy modeled on the Trump administration, tightening regulations and cutting funding that many disability advocates say will strain the home‑car…